
ACCEL Lite: Statins To Prevent The Cardiotoxicity From Anthracyclines: The STOP-CA Trial
Sid'Ahmed Abdelahi
Description
<div class="OutlineElement Ltr SCXW258216288 BCX0"> </div> <div class="OutlineElement Ltr SCXW258216288 BCX0"> <p class="MsoNormal"><span style= "font-family: 'Times New Roman',serif; mso-no-proof: yes;">Patients receiving chemotherapy regimens containing anthracyclines for lymphoma were significantly less likely to show evidence of heart dysfunction after taking atorvastatin for 12 months, according to research from the STOP-CA trial, a multicenter, randomized, double-blind, placebo-controlled study presented at ACC.23/WCC.</span></p> <p class="MsoNormal"><span style= "font-family: 'Times New Roman',serif; mso-no-proof: yes;"> </span><span style="font-family: 'Times New Roman',serif;">In this interview, <span style="mso-no-proof: yes;">Bonnie Ky MD, MSCE and Anthony N. DeMaria MD, MACC</span> discuss “<span style= "mso-no-proof: yes;">Statins To Prevent The Cardiotoxicity From Anthracyclines: The STOP-CA Trial.”</span></span></p> <p class="MsoNormal"><span style= "font-family: 'Times New Roman',serif;"> </span><a href= "https://itunes.apple.com/us/podcast/eagles-eye-view-your-weekly-cv-update-from-acc-org/id1274635046">Subscribe on Apple</a> <span class="MsoHyperlink">Podcasts</span> <span style="font-family: 'Times New Roman',serif;">|</span> <a href= "https://play.google.com/music/listen#/ps/I6dtkumvaipematzgzmbph2koiq"> Subscribe on Google Play</a> <span class="MsoHyperlink">|</span> <a href= "http://www.acc.org/education-and-meetings/products-and-resources/accel-audio"> Subscribe to ACCEL</a></p> </div> <div class="OutlineElement Ltr SCXW258216288 BCX0"> <p class="Paragraph SCXW258216288 BCX0"> </p> </div>
Uploader
Episodes
ACCEL Lite: Statins To Prevent The Cardiotoxicity From Anthracyclines: The STOP-CA Trial
Sid'Ahmed Abdelahi